Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (67) clinical trials

A study to evaluate the safety and efficacy of an investigational drug in subjects with moderate to severe Crohn's disease. REF: 001-CGI

Phase

Do you suffer from Crohn’s Disease? Wake Research Associates is enrolling volunteers with Crohn’s in a clinical research study of an investigational medication.

Phase

Wake Research Associates is looking for volunteers for a research study of an investigational drug for moderate to severe Crohn’s disease. The study will test the drug’s safety and effectiveness.

Phase

The primary objective of this study is to evaluate the efficacy of filgotinib as compared to placebo in establishing combined fistula response at Week 24. Participants will have the option to enter a separate long-term extension study if they meet eligibility requirements.

Phase

The primary objective of this study is to evaluate the efficacy of filgotinib, when compared to placebo, in establishing clinical remission in participants with Crohn's disease involving the small bowel. Participants will have the option to enter a separate long-term extension study if they meet eligibility requirements.

Phase

This study is designed to evaluate the effect of treatment with filgotinib on testicular safety in adult males with moderately to severely active Ulcerative Colitis (UC). Stipend range: $75o/v, $100proc For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 195 ...

Phase

This is a phase 2a, randomized, double-blind, placebo-controlled, parallel group, multicenter study in subjects with active UC and a non-remission response to infliximab.   There will be up to 13 study visits, across the 12 weeks of treatment, along with 2 follow-up visits, at Weeks 16 and 22. Ideal patients ...

Phase

The primary objective of this study is to evaluate the testicular safety of filgotinib in adult males with moderately to severely active ulcerative colitis.

Phase

To demonstrate the efficacy of study drug, SER-287, to induce clinical remission in patients with active mild-to-moderate ulcerative colitis.  

Phase

This Phase 2 study is designed to evaluate the efficacy and safety of itacitinib in men and women with moderate to severe UC. The study consists of Part A and Part B, which consist of 12 weeks of double-blind, randomized, placebo-controlled treatment periods followed by 40 weeks open label extension ...

Phase